The research proposed here derives from an unexpected convergence of two areas of current cancer research. One area describes the fact that carcinoma cells exploit certain cell-biological programs that are usually operative in normal embryonic development and function to convert epithelial cells to cells that have a more mesenchymal (connective tissue-like) appearance and behavior. This conversion is often termed an epithelial-mesenchymal transition (EMT) and, when appropriated by carcinoma cells, serves to impart to these cells critical powers, such as invasiveness and motility, both of which are essential for cancer cell metastasis. A second research area has addressed the existence of small minorities of self-renewing cancer cells that exist amid far larger numbers of non-self-renewing cancer cells within tumors. The minority cells, often termed cancer stem cells (CSCs), are capable of seeding new tumors, while the cancer cells forming the majority of cells within a tumor lack this ability. These CSCs mirror the behavior of the stem cells in normal tissues, which also constitute small minorities of the total cell populations in such tissues and, because of their self-renewing abilities, are also responsible for the regenerative abilities of these normal tissues. Recent research has revealed that when normal mammary epithelial cells (MECs) are induced to undergo an EMT, they acquire the self-renewing powers of normal epithelial stem cells. Analogously, when tumor cells are forced to undergo an EMT, they acquire far greater tumor-initiating ability and thus are likely to be CSCs. The ramifications of these recent findings will be explored in the proposed research. For example, there is reason to believe that an EMT suffices to convey carcinoma cells from a primary tumor to a site of distant metastasis. Some of this research will examine whether the resulting disseminated cells, having experienced an EMT, now gain the ability to form macroscopic metastases. This research will also reveal whether CSCs arise preferentially from normal cells, or whether they can be formed equally efficiently from normal non-stem cells. In addition, genetically altered mice will be constructed whose cells fluoresce in the event that they activate one of the several transcription factors that are known to program the EMT. The cells of these mice will make it possible to screen for the cell-to-cell signals that induce epithelial cells to undergo the EMT and induce non-stem cells to become stem cells.

Public Health Relevance

While being responsible for ~90% of cancer related mortality, the process of cancer-cell metastasis remains poorly understood;many of its steps are now being revealed by studying cell-biological changes that occur during early embryonic development. These changes also impart to cancer cells an ability to regenerate themselves, yielding """"""""cancer stem cells"""""""" that can seed new tumors. The ability to produce large numbers of such cancer stem cells, as described in the proposed research, may present an opportunity to develop novel anti-cancer drugs that are able to eliminate tumors by eliminating the stem cells that allow tumors to grow back after initially successful treatments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078461-11
Application #
7750606
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Mohla, Suresh
Project Start
1999-09-30
Project End
2013-11-30
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
11
Fiscal Year
2010
Total Cost
$494,697
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Keckesova, Zuzana; Donaher, Joana Liu; De Cock, Jasmine et al. (2017) LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature 543:681-686
Bierie, Brian; Pierce, Sarah E; Kroeger, Cornelia et al. (2017) Integrin-?4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A 114:E2337-E2346
Lambert, Arthur W; Pattabiraman, Diwakar R; Weinberg, Robert A (2017) Emerging Biological Principles of Metastasis. Cell 168:670-691
Pattabiraman, Diwakar R; Weinberg, Robert A (2016) Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy. Cold Spring Harb Symp Quant Biol 81:11-19
Pattabiraman, Diwakar R; Bierie, Brian; Kober, Katharina Isabelle et al. (2016) Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science 351:aad3680
De Cock, Jasmine M; Shibue, Tsukasa; Dongre, Anushka et al. (2016) Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency. Cancer Res 76:6778-6784
Chaffer, Christine L; Weinberg, Robert A (2015) How does multistep tumorigenesis really proceed? Cancer Discov 5:22-4
Ye, Xin; Tam, Wai Leong; Shibue, Tsukasa et al. (2015) Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525:256-60
Watnick, R S; Rodriguez, R K; Wang, S et al. (2015) Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells. Oncogene 34:2823-35
Ye, Xin; Weinberg, Robert A (2015) Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol 25:675-86

Showing the most recent 10 out of 41 publications